Ghana Sovereign Wealth Fund to Invest in Ewoyaa Project
The Minerals Income Investment Fund of Ghana to acquire 6% interest in Ewoyaa for $27.9…
3 years ago
Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK-279, a Highly Selective Oral TYK2 Inhibitor, for the Treatment of Active Psoriatic Arthritis
− Topline Results for TAK-279 Show that a Significantly Greater Proportion of Psoriatic Arthritis Patients…
3 years ago
Vista Gold Corp. Presenting at the 2023 Precious Metals Summit
DENVER--(BUSINESS WIRE)--Vista Gold Corp. (NYSE American and TSX: VGZ) (“Vista†or the “Companyâ€) announced today…
3 years ago
Netcracker Launches Pioneering Solution to Advance Generative AI for the Telecom Industry
Netcracker GenAI Telco Solution Accelerates the Adoption of High-Value Use Cases Across the Telecom Business…
3 years ago
Heartseed Announces the Presentation of HS-001, an Investigational Stem Cell-Derived Therapy for the Treatment of Advanced Heart Failure at the 71st Annual Meeting of the Japanese College of Cardiology
TOKYO--(BUSINESS WIRE)--#HS001--Heartseed (Heartseed Inc.), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for heart failure, today…
3 years ago
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
Clinical trials will advance treatment of COVID-19 infection. BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (“SINOVAC†or the…
3 years ago
Calling All Pet Lovers! Starstreet Precinct Takes Your Furry Friends on a Pawsome Adventure
HONG KONG SAR - Media OutReach - 11 September 2023 - Known for its variety…
3 years ago
AustralianSuper Backs Vantage Data Centers with €1.5 Billion Investment and Joins DigitalBridge as Key Shareholder
MELBOURNE, Australia & BOCA RATON, Fla. & DENVER--(BUSINESS WIRE)--AustralianSuper, Australia’s largest pension fund, today announced…
3 years ago
ENHERTU® Demonstrated Strong and Durable Tumor Responses in Previously Treated HER2 Mutant Advanced Lung Cancer in DESTINY-Lung02 Phase 2 Trial
Daiichi Sankyo and AstraZeneca’s ENHERTU showed objective response rates of 49% and 56% with 5.4…
3 years ago
Global Chemicals Market 2023 to 2027, Fueled by Growing Demand Across Industries – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Chemicals Market (by Category & Region): Insights & Forecast with Potential Impact…
3 years ago